nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Infection—Methylprednisolone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Methylphenidate—Haematuria—Methotrexate—ankylosing spondylitis	0.000942	0.000942	CcSEcCtD
Methylphenidate—Shock—Triamcinolone—ankylosing spondylitis	0.000938	0.000938	CcSEcCtD
Methylphenidate—Insomnia—Prednisolone—ankylosing spondylitis	0.000938	0.000938	CcSEcCtD
Methylphenidate—Alopecia—Prednisone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Methylphenidate—Shock—Methylprednisolone—ankylosing spondylitis	0.000936	0.000936	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000934	0.000934	CcSEcCtD
Methylphenidate—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000933	0.000933	CcSEcCtD
Methylphenidate—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Methylphenidate—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Methylphenidate—Epistaxis—Methotrexate—ankylosing spondylitis	0.000931	0.000931	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000931	0.000931	CcSEcCtD
Methylphenidate—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000931	0.000931	CcSEcCtD
Methylphenidate—Mental disorder—Prednisone—ankylosing spondylitis	0.000929	0.000929	CcSEcCtD
Methylphenidate—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000929	0.000929	CcSEcCtD
Methylphenidate—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000924	0.000924	CcSEcCtD
Methylphenidate—Erythema—Prednisone—ankylosing spondylitis	0.000923	0.000923	CcSEcCtD
Methylphenidate—Malnutrition—Prednisone—ankylosing spondylitis	0.000923	0.000923	CcSEcCtD
Methylphenidate—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000922	0.000922	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00092	0.00092	CcSEcCtD
Methylphenidate—Convulsion—Dexamethasone—ankylosing spondylitis	0.000919	0.000919	CcSEcCtD
Methylphenidate—Convulsion—Betamethasone—ankylosing spondylitis	0.000919	0.000919	CcSEcCtD
Methylphenidate—Hypertension—Dexamethasone—ankylosing spondylitis	0.000915	0.000915	CcSEcCtD
Methylphenidate—Hypertension—Betamethasone—ankylosing spondylitis	0.000915	0.000915	CcSEcCtD
Methylphenidate—Myalgia—Dexamethasone—ankylosing spondylitis	0.000903	0.000903	CcSEcCtD
Methylphenidate—Myalgia—Betamethasone—ankylosing spondylitis	0.000903	0.000903	CcSEcCtD
Methylphenidate—Anxiety—Betamethasone—ankylosing spondylitis	0.0009	0.0009	CcSEcCtD
Methylphenidate—Anxiety—Dexamethasone—ankylosing spondylitis	0.0009	0.0009	CcSEcCtD
Methylphenidate—Discomfort—Dexamethasone—ankylosing spondylitis	0.000892	0.000892	CcSEcCtD
Methylphenidate—Discomfort—Betamethasone—ankylosing spondylitis	0.000892	0.000892	CcSEcCtD
Methylphenidate—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000891	0.000891	CcSEcCtD
Methylphenidate—Pain—Prednisolone—ankylosing spondylitis	0.000887	0.000887	CcSEcCtD
Methylphenidate—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000886	0.000886	CcSEcCtD
Methylphenidate—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00088	0.00088	CcSEcCtD
Methylphenidate—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000875	0.000875	CcSEcCtD
Methylphenidate—Vision blurred—Prednisone—ankylosing spondylitis	0.00087	0.00087	CcSEcCtD
Methylphenidate—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000867	0.000867	CcSEcCtD
Methylphenidate—Oedema—Betamethasone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Methylphenidate—Oedema—Dexamethasone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Methylphenidate—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Methylphenidate—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000865	0.000865	CcSEcCtD
Methylphenidate—Insomnia—Triamcinolone—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Methylphenidate—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000861	0.000861	CcSEcCtD
Methylphenidate—Infection—Betamethasone—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Methylphenidate—Infection—Dexamethasone—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Methylphenidate—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000857	0.000857	CcSEcCtD
Methylphenidate—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000856	0.000856	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000855	0.000855	CcSEcCtD
Methylphenidate—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000854	0.000854	CcSEcCtD
Methylphenidate—Visual impairment—Methotrexate—ankylosing spondylitis	0.000854	0.000854	CcSEcCtD
Methylphenidate—Anaemia—Prednisone—ankylosing spondylitis	0.000853	0.000853	CcSEcCtD
Methylphenidate—Shock—Betamethasone—ankylosing spondylitis	0.000851	0.000851	CcSEcCtD
Methylphenidate—Shock—Dexamethasone—ankylosing spondylitis	0.000851	0.000851	CcSEcCtD
Methylphenidate—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00085	0.00085	CcSEcCtD
Methylphenidate—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000849	0.000849	CcSEcCtD
Methylphenidate—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000849	0.000849	CcSEcCtD
Methylphenidate—Agitation—Prednisone—ankylosing spondylitis	0.000849	0.000849	CcSEcCtD
Methylphenidate—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000847	0.000847	CcSEcCtD
Methylphenidate—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000847	0.000847	CcSEcCtD
Methylphenidate—Tachycardia—Betamethasone—ankylosing spondylitis	0.000845	0.000845	CcSEcCtD
Methylphenidate—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000845	0.000845	CcSEcCtD
Methylphenidate—Angioedema—Prednisone—ankylosing spondylitis	0.000844	0.000844	CcSEcCtD
Methylphenidate—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Methylphenidate—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000838	0.000838	CcSEcCtD
Methylphenidate—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000838	0.000838	CcSEcCtD
Methylphenidate—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000837	0.000837	CcSEcCtD
Methylphenidate—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000837	0.000837	CcSEcCtD
Methylphenidate—Malaise—Prednisone—ankylosing spondylitis	0.000833	0.000833	CcSEcCtD
Methylphenidate—Vertigo—Prednisone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Methylphenidate—Eye disorder—Methotrexate—ankylosing spondylitis	0.000828	0.000828	CcSEcCtD
Methylphenidate—Syncope—Prednisone—ankylosing spondylitis	0.000828	0.000828	CcSEcCtD
Methylphenidate—Anorexia—Dexamethasone—ankylosing spondylitis	0.000825	0.000825	CcSEcCtD
Methylphenidate—Anorexia—Betamethasone—ankylosing spondylitis	0.000825	0.000825	CcSEcCtD
Methylphenidate—Urticaria—Prednisolone—ankylosing spondylitis	0.000824	0.000824	CcSEcCtD
Methylphenidate—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Methylphenidate—Fatigue—Triamcinolone—ankylosing spondylitis	0.000822	0.000822	CcSEcCtD
Methylphenidate—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00082	0.00082	CcSEcCtD
Methylphenidate—Pain—Triamcinolone—ankylosing spondylitis	0.000816	0.000816	CcSEcCtD
Methylphenidate—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000812	0.000812	CcSEcCtD
Methylphenidate—Angiopathy—Methotrexate—ankylosing spondylitis	0.000804	0.000804	CcSEcCtD
Methylphenidate—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000801	0.000801	CcSEcCtD
Methylphenidate—Convulsion—Prednisone—ankylosing spondylitis	0.0008	0.0008	CcSEcCtD
Methylphenidate—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000799	0.000799	CcSEcCtD
Methylphenidate—Hypertension—Prednisone—ankylosing spondylitis	0.000797	0.000797	CcSEcCtD
Methylphenidate—Chills—Methotrexate—ankylosing spondylitis	0.000795	0.000795	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000788	0.000788	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000788	0.000788	CcSEcCtD
Methylphenidate—Myalgia—Prednisone—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Methylphenidate—Arthralgia—Prednisone—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Methylphenidate—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Methylphenidate—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000784	0.000784	CcSEcCtD
Methylphenidate—Anxiety—Prednisone—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Methylphenidate—Alopecia—Methotrexate—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Methylphenidate—Insomnia—Dexamethasone—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Methylphenidate—Insomnia—Betamethasone—ankylosing spondylitis	0.000783	0.000783	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000781	0.000781	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000778	0.000778	CcSEcCtD
Methylphenidate—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000777	0.000777	CcSEcCtD
Methylphenidate—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000777	0.000777	CcSEcCtD
Methylphenidate—Discomfort—Prednisone—ankylosing spondylitis	0.000777	0.000777	CcSEcCtD
Methylphenidate—Mental disorder—Methotrexate—ankylosing spondylitis	0.000777	0.000777	CcSEcCtD
Methylphenidate—Erythema—Methotrexate—ankylosing spondylitis	0.000772	0.000772	CcSEcCtD
Methylphenidate—Malnutrition—Methotrexate—ankylosing spondylitis	0.000772	0.000772	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000764	0.000764	CcSEcCtD
Methylphenidate—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000762	0.000762	CcSEcCtD
Methylphenidate—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000762	0.000762	CcSEcCtD
Methylphenidate—Urticaria—Triamcinolone—ankylosing spondylitis	0.000758	0.000758	CcSEcCtD
Methylphenidate—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Methylphenidate—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Methylphenidate—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Methylphenidate—Oedema—Prednisone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Methylphenidate—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Methylphenidate—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Methylphenidate—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Methylphenidate—Infection—Prednisone—ankylosing spondylitis	0.000749	0.000749	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000747	0.000747	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000747	0.000747	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Methylphenidate—Fatigue—Betamethasone—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Methylphenidate—Fatigue—Dexamethasone—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Methylphenidate—Shock—Prednisone—ankylosing spondylitis	0.000741	0.000741	CcSEcCtD
Methylphenidate—Pain—Dexamethasone—ankylosing spondylitis	0.00074	0.00074	CcSEcCtD
Methylphenidate—Pain—Betamethasone—ankylosing spondylitis	0.00074	0.00074	CcSEcCtD
Methylphenidate—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000739	0.000739	CcSEcCtD
Methylphenidate—Tachycardia—Prednisone—ankylosing spondylitis	0.000735	0.000735	CcSEcCtD
Methylphenidate—Skin disorder—Prednisone—ankylosing spondylitis	0.000732	0.000732	CcSEcCtD
Methylphenidate—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000728	0.000728	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—ankylosing spondylitis	0.000727	0.000727	CcSEcCtD
Methylphenidate—Anorexia—Prednisone—ankylosing spondylitis	0.000718	0.000718	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000716	0.000716	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—ankylosing spondylitis	0.000713	0.000713	CcSEcCtD
Methylphenidate—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000713	0.000713	CcSEcCtD
Methylphenidate—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000713	0.000713	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000708	0.000708	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000708	0.000708	CcSEcCtD
Methylphenidate—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000703	0.000703	CcSEcCtD
Methylphenidate—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000701	0.000701	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—ankylosing spondylitis	0.000696	0.000696	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—ankylosing spondylitis	0.000693	0.000693	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—ankylosing spondylitis	0.000691	0.000691	CcSEcCtD
Methylphenidate—Urticaria—Betamethasone—ankylosing spondylitis	0.000687	0.000687	CcSEcCtD
Methylphenidate—Urticaria—Dexamethasone—ankylosing spondylitis	0.000687	0.000687	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000687	0.000687	CcSEcCtD
Methylphenidate—Dizziness—Prednisolone—ankylosing spondylitis	0.000686	0.000686	CcSEcCtD
Methylphenidate—Asthenia—Triamcinolone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Methylphenidate—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000683	0.000683	CcSEcCtD
Methylphenidate—Insomnia—Prednisone—ankylosing spondylitis	0.000682	0.000682	CcSEcCtD
Methylphenidate—Paraesthesia—Prednisone—ankylosing spondylitis	0.000677	0.000677	CcSEcCtD
Methylphenidate—Pruritus—Triamcinolone—ankylosing spondylitis	0.000675	0.000675	CcSEcCtD
Methylphenidate—Cough—Methotrexate—ankylosing spondylitis	0.000673	0.000673	CcSEcCtD
Methylphenidate—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000673	0.000673	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—ankylosing spondylitis	0.000669	0.000669	CcSEcCtD
Methylphenidate—Dyspepsia—Prednisone—ankylosing spondylitis	0.000663	0.000663	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—ankylosing spondylitis	0.000657	0.000657	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—ankylosing spondylitis	0.000657	0.000657	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—ankylosing spondylitis	0.000657	0.000657	CcSEcCtD
Methylphenidate—Decreased appetite—Prednisone—ankylosing spondylitis	0.000655	0.000655	CcSEcCtD
Methylphenidate—Rash—Prednisolone—ankylosing spondylitis	0.000654	0.000654	CcSEcCtD
Methylphenidate—Dermatitis—Prednisolone—ankylosing spondylitis	0.000653	0.000653	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000652	0.000652	CcSEcCtD
Methylphenidate—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000651	0.000651	CcSEcCtD
Methylphenidate—Fatigue—Prednisone—ankylosing spondylitis	0.00065	0.00065	CcSEcCtD
Methylphenidate—Headache—Prednisolone—ankylosing spondylitis	0.00065	0.00065	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—ankylosing spondylitis	0.000649	0.000649	CcSEcCtD
Methylphenidate—Constipation—Prednisone—ankylosing spondylitis	0.000644	0.000644	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—ankylosing spondylitis	0.000635	0.000635	CcSEcCtD
Methylphenidate—Dizziness—Triamcinolone—ankylosing spondylitis	0.000631	0.000631	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00063	0.00063	CcSEcCtD
Methylphenidate—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000629	0.000629	CcSEcCtD
Methylphenidate—Infection—Methotrexate—ankylosing spondylitis	0.000626	0.000626	CcSEcCtD
Methylphenidate—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000621	0.000621	CcSEcCtD
Methylphenidate—Asthenia—Betamethasone—ankylosing spondylitis	0.000621	0.000621	CcSEcCtD
Methylphenidate—Asthenia—Dexamethasone—ankylosing spondylitis	0.000621	0.000621	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000618	0.000618	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000617	0.000617	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000616	0.000616	CcSEcCtD
Methylphenidate—Nausea—Prednisolone—ankylosing spondylitis	0.000616	0.000616	CcSEcCtD
Methylphenidate—Pruritus—Betamethasone—ankylosing spondylitis	0.000612	0.000612	CcSEcCtD
Methylphenidate—Pruritus—Dexamethasone—ankylosing spondylitis	0.000612	0.000612	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—ankylosing spondylitis	0.000612	0.000612	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000609	0.000609	CcSEcCtD
Methylphenidate—Vomiting—Triamcinolone—ankylosing spondylitis	0.000606	0.000606	CcSEcCtD
Methylphenidate—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000605	0.000605	CcSEcCtD
Methylphenidate—Rash—Triamcinolone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Methylphenidate—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—ankylosing spondylitis	0.0006	0.0006	CcSEcCtD
Methylphenidate—Rash—Methylprednisolone—ankylosing spondylitis	0.0006	0.0006	CcSEcCtD
Methylphenidate—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000599	0.000599	CcSEcCtD
Methylphenidate—Urticaria—Prednisone—ankylosing spondylitis	0.000599	0.000599	CcSEcCtD
Methylphenidate—Headache—Triamcinolone—ankylosing spondylitis	0.000597	0.000597	CcSEcCtD
Methylphenidate—Headache—Methylprednisolone—ankylosing spondylitis	0.000596	0.000596	CcSEcCtD
Methylphenidate—Abdominal pain—Prednisone—ankylosing spondylitis	0.000596	0.000596	CcSEcCtD
Methylphenidate—Body temperature increased—Prednisone—ankylosing spondylitis	0.000596	0.000596	CcSEcCtD
Methylphenidate—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000592	0.000592	CcSEcCtD
Methylphenidate—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000592	0.000592	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000574	0.000574	CcSEcCtD
Methylphenidate—Dizziness—Dexamethasone—ankylosing spondylitis	0.000572	0.000572	CcSEcCtD
Methylphenidate—Dizziness—Betamethasone—ankylosing spondylitis	0.000572	0.000572	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—ankylosing spondylitis	0.00057	0.00057	CcSEcCtD
Methylphenidate—Nausea—Triamcinolone—ankylosing spondylitis	0.000566	0.000566	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000566	0.000566	CcSEcCtD
Methylphenidate—Nausea—Methylprednisolone—ankylosing spondylitis	0.000565	0.000565	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000561	0.000561	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—ankylosing spondylitis	0.00056	0.00056	CcSEcCtD
Methylphenidate—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000555	0.000555	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000554	0.000554	CcSEcCtD
Methylphenidate—Vomiting—Betamethasone—ankylosing spondylitis	0.00055	0.00055	CcSEcCtD
Methylphenidate—Vomiting—Dexamethasone—ankylosing spondylitis	0.00055	0.00055	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000547	0.000547	CcSEcCtD
Methylphenidate—Rash—Dexamethasone—ankylosing spondylitis	0.000546	0.000546	CcSEcCtD
Methylphenidate—Rash—Betamethasone—ankylosing spondylitis	0.000546	0.000546	CcSEcCtD
Methylphenidate—Dermatitis—Betamethasone—ankylosing spondylitis	0.000545	0.000545	CcSEcCtD
Methylphenidate—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000545	0.000545	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000544	0.000544	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—ankylosing spondylitis	0.000543	0.000543	CcSEcCtD
Methylphenidate—Headache—Betamethasone—ankylosing spondylitis	0.000542	0.000542	CcSEcCtD
Methylphenidate—Headache—Dexamethasone—ankylosing spondylitis	0.000542	0.000542	CcSEcCtD
Methylphenidate—Asthenia—Prednisone—ankylosing spondylitis	0.000541	0.000541	CcSEcCtD
Methylphenidate—Pain—Methotrexate—ankylosing spondylitis	0.000539	0.000539	CcSEcCtD
Methylphenidate—Pruritus—Prednisone—ankylosing spondylitis	0.000533	0.000533	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000519	0.000519	CcSEcCtD
Methylphenidate—Diarrhoea—Prednisone—ankylosing spondylitis	0.000516	0.000516	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000515	0.000515	CcSEcCtD
Methylphenidate—Nausea—Betamethasone—ankylosing spondylitis	0.000514	0.000514	CcSEcCtD
Methylphenidate—Nausea—Dexamethasone—ankylosing spondylitis	0.000514	0.000514	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—ankylosing spondylitis	0.0005	0.0005	CcSEcCtD
Methylphenidate—Dizziness—Prednisone—ankylosing spondylitis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000498	0.000498	CcSEcCtD
Methylphenidate—Vomiting—Prednisone—ankylosing spondylitis	0.000479	0.000479	CcSEcCtD
Methylphenidate—Rash—Prednisone—ankylosing spondylitis	0.000475	0.000475	CcSEcCtD
Methylphenidate—Dermatitis—Prednisone—ankylosing spondylitis	0.000475	0.000475	CcSEcCtD
Methylphenidate—Headache—Prednisone—ankylosing spondylitis	0.000472	0.000472	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000464	0.000464	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—ankylosing spondylitis	0.000452	0.000452	CcSEcCtD
Methylphenidate—Nausea—Prednisone—ankylosing spondylitis	0.000448	0.000448	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—ankylosing spondylitis	0.000446	0.000446	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000431	0.000431	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—ankylosing spondylitis	0.000416	0.000416	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—ankylosing spondylitis	0.0004	0.0004	CcSEcCtD
Methylphenidate—Rash—Methotrexate—ankylosing spondylitis	0.000397	0.000397	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—ankylosing spondylitis	0.000397	0.000397	CcSEcCtD
Methylphenidate—Headache—Methotrexate—ankylosing spondylitis	0.000395	0.000395	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—ankylosing spondylitis	0.000374	0.000374	CcSEcCtD
